First-Line CDK4/6 Thumps Chemo in Aggressive, Advanced Breast Cancer

(MedPage Today) -- SAN ANTONIO--A CDK4/6 inhibitor plus endocrine therapy combination extended progression-free survival (PFS) by nearly a year compared with chemotherapy as first-line treatment for premenopausal patients with aggressive, hormone...